Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05864612 · ClinicalTrials.gov registry record · NA
Tools for Anxiety and Depression Screening in Epilepsy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 880
- Enrollment target
NCT05864612 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 880 participants.
The verdict
NCT05864612, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 880 participants
- Enrollment target
Study Summary
A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.
Interventions
- BEHAVIORAL Screening Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2024-09-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05864612
The ClinicalTrials.gov registry entry for NCT05864612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 880 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening Questionnaires is the first listed.
NCT05864612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05864612 about?
NCT05864612 is a clinical study titled "Tools for Anxiety and Depression Screening in Epilepsy". A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.
What is the current status of trial NCT05864612?
This trial is currently completed. It is a NA study. The enrollment target is 880 participants. The study started on 2023-09-20. Estimated completion is 2024-09-03.
What interventions are being tested in trial NCT05864612?
The interventions under investigation include: Screening Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05864612?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.